Close

SVB Leerink Downgrades Alexion Pharmaceuticals (ALXN) to Market Perform

March 23, 2021 6:49 AM EDT Send to a Friend
SVB Leerink analyst Geoffrey Porges downgraded Alexion Pharmaceuticals (NASDAQ: ALXN) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login